Literature DB >> 17267074

Enhanced activation of pro-inflammatory cytokines in mice lacking natriuretic peptide receptor-A.

Elangovan Vellaichamy1, Kiran Kaur, Kailash N Pandey.   

Abstract

Natriuretic peptide receptor-A (NPRA) is the principal receptor for the cardiac hormones ANP and BNP. Mice lacking NPRA develop progressive cardiac hypertrophy and congestive heart failure. However, the mechanisms responsible for hypertrophic growth in the absence of NPRA signaling are not yet known. In the present study, we determined whether deficiency of NPRA/cGMP signaling alters the cardiac pro-inflammatory cytokines gene expression in Npr1 (coding for NPRA) gene-knockout (Npr1(-/-)) mice exhibiting cardiac hypertrophy and fibrosis as compared with control wild-type (Npr1(+/+)) mice. A significant up-regulation of cytokine genes such as TNF-alpha (five-fold), IL-6 (three-fold) and TGF-beta1 (four-fold) were observed in mutant mice hearts lacking NPRA as compared with the age-matched wild-type mice. In parallel, NF-kappaB binding activity was almost five-fold greater in the nuclear extract of Npr1(-/-) mutant mice hearts as compared with wild-type Npr1(+/+) mice hearts. Guanylyl cyclase (GC) activity and cGMP levels were drastically reduced by 10- and 5-fold, respectively, in ventricular tissues of mutant mice hearts relative to wild-type controls. The present findings provide direct evidence that ablation of NPRA/cGMP signaling activates inflammatory cytokines, probably via NF-kappaB mediated signaling pathway, and is associated with hypertrophic growth of null mutant mice hearts.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17267074      PMCID: PMC2743377          DOI: 10.1016/j.peptides.2006.12.009

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  33 in total

1.  Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes.

Authors:  N H Purcell; G Tang; C Yu; F Mercurio; J A DiDonato; A Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

2.  Atrial natriuretic peptide inhibits tumor necrosis factor-alpha production by interferon-gamma-activated macrophages via suppression of p38 mitogen-activated protein kinase and nuclear factor-kappa B activation.

Authors:  H Tsukagoshi; Y Shimizu; T Kawata; T Hisada; Y Shimizu; S Iwamae; T Ishizuka; K Iizuka; K Dobashi; M Mori
Journal:  Regul Pept       Date:  2001-05-05

3.  Natriuretic peptide receptor-A negatively regulates mitogen-activated protein kinase and proliferation of mesangial cells: role of cGMP-dependent protein kinase.

Authors:  K N Pandey; H T Nguyen; M Li; J W Boyle
Journal:  Biochem Biophys Res Commun       Date:  2000-05-10       Impact factor: 3.575

4.  A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy.

Authors:  I Kishimoto; K Rossi; D L Garbers
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

5.  Load-dependent and -independent regulation of proinflammatory cytokine and cytokine receptor gene expression in the adult mammalian heart.

Authors:  Georg Baumgarten; Pascal Knuefermann; Dinesh Kalra; Feng Gao; George E Taffet; Lloyd Michael; Perry J Blackshear; Ester Carballo; Natarajan Sivasubramanian; Douglas L Mann
Journal:  Circulation       Date:  2002-05-07       Impact factor: 29.690

6.  Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB.

Authors:  L V Madrid; C Y Wang; D C Guttridge; A J Schottelius; A S Baldwin; M W Mayo
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

7.  Interleukin-6 family of cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes.

Authors:  M Sano; K Fukuda; H Kodama; J Pan; M Saito; J Matsuzaki; T Takahashi; S Makino; T Kato; S Ogawa
Journal:  J Biol Chem       Date:  2000-09-22       Impact factor: 5.157

8.  Myocardial proinflammatory cytokine expression and left ventricular remodeling in patients with chronic mitral regurgitation.

Authors:  Hakan Oral; Natarajan Sivasubramanian; David B Dyke; Rajendra H Mehta; P Michael Grossman; Kerri Briesmiester; William P Fay; Francis D Pagani; Steven F Bolling; Douglas L Mann; Mark R Starling
Journal:  Circulation       Date:  2003-02-18       Impact factor: 29.690

9.  Differential expression of TNF-alpha, IL-6, and IGF-1 by graded mechanical stress in normal rat myocardium.

Authors:  Emiliano A Palmieri; Giulio Benincasa; Francesca Di Rella; Cosma Casaburi; Maria G Monti; Giuseppe De Simone; Lorenzo Chiariotti; Lucio Palombini; Carmelo B Bruni; Luigi Saccà; Antonio Cittadini
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-03       Impact factor: 4.733

10.  Induction of IkappaB: atrial natriuretic peptide as a regulator of the NF-kappaB pathway.

Authors:  Alexandra K Kiemer; Nina C Weber; Angelika M Vollmar
Journal:  Biochem Biophys Res Commun       Date:  2002-08-02       Impact factor: 3.575

View more
  18 in total

1.  Activation of IKK/NF-κB provokes renal inflammatory responses in guanylyl cyclase/natriuretic peptide receptor-A gene-knockout mice.

Authors:  Subhankar Das; Ramu Periyasamy; Kailash N Pandey
Journal:  Physiol Genomics       Date:  2012-02-07       Impact factor: 3.107

2.  CRRL269.

Authors:  Yang Chen; Gail J Harty; Ye Zheng; Seethalakshmi R Iyer; Shinobu Sugihara; S Jeson Sangaralingham; Tomoko Ichiki; Joseph P Grande; Hon-Chi Lee; Xiaoli Wang; John C Burnett
Journal:  Circ Res       Date:  2019-05-10       Impact factor: 17.367

3.  Genetic disruption of Npr1 depletes regulatory T cells and provokes high levels of proinflammatory cytokines and fibrosis in the kidneys of female mutant mice.

Authors:  Venkateswara Reddy Gogulamudi; Indra Mani; Umadevi Subramanian; Kailash N Pandey
Journal:  Am J Physiol Renal Physiol       Date:  2019-04-03

Review 4.  Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target.

Authors:  N Glezeva; J A Baugh
Journal:  Heart Fail Rev       Date:  2014-09       Impact factor: 4.214

5.  Attenuation of monocyte chemotaxis--a novel anti-inflammatory mechanism of action for the cardio-protective hormone B-type natriuretic peptide.

Authors:  Nadezhda Glezeva; Patrick Collier; Victor Voon; Mark Ledwidge; Kenneth McDonald; Chris Watson; John Baugh
Journal:  J Cardiovasc Transl Res       Date:  2013-04-27       Impact factor: 4.132

6.  Murine guanylate cyclase C regulates colonic injury and inflammation.

Authors:  Kris A Steinbrecher; Eleana Harmel-Laws; Monica P Garin-Laflam; Elizabeth A Mann; Lucas D Bezerra; Simon P Hogan; Mitchell B Cohen
Journal:  J Immunol       Date:  2011-05-09       Impact factor: 5.422

Review 7.  Genetic variation in the natriuretic peptide system and heart failure.

Authors:  David E Lanfear
Journal:  Heart Fail Rev       Date:  2008-10-11       Impact factor: 4.214

8.  Suppression of atrial natriuretic peptide/natriuretic peptide receptor-A-mediated signaling upregulates angiotensin-II-induced collagen synthesis in adult cardiac fibroblasts.

Authors:  Arumugam Parthasarathy; Venkatachalam Gopi; Subramanian Umadevi; Anoop Simna; Mohammed Jainuddin Yousuf Sheik; H Divya; Elangovan Vellaichamy
Journal:  Mol Cell Biochem       Date:  2013-03-23       Impact factor: 3.396

9.  Transforming growth factor β1 antagonizes the transcription, expression and vascular signaling of guanylyl cyclase/natriuretic peptide receptor A - role of δEF1.

Authors:  Anagha Sen; Prerna Kumar; Renu Garg; Sarah H Lindsey; Prasad V G Katakam; Meaghan Bloodworth; Kailash N Pandey
Journal:  FEBS J       Date:  2016-04-05       Impact factor: 5.542

Review 10.  Pharmacogenomics of the Natriuretic Peptide System in Heart Failure.

Authors:  Ahmed Abuzaanona; David Lanfear
Journal:  Curr Heart Fail Rep       Date:  2017-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.